Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.267ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.391ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.274ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AY.39.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.637ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.7.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BQ.1.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
CK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.7.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
CM.8.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
C.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AY.121.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.277ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.412ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BA.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BA.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BQ.1.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-4085China
BQ.1.1.70SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
XBB.1.9SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
FL.25SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
BA.2.33SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
FL.39.1SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
KT.1.2SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
JN.1.7.7SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
JN.3.2SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
unclassifiableSNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
JN.1.4.6SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
DV.7.2SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
BA.2.58NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4175.44US
B.19NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4177.06Thailand
B.1.1.515NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4177.06Thailand
B.1.287NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4177.06Thailand
BA.1.17.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4177.06Thailand
B.1.1.74NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-4177.83Japan
BA.2.56ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
B.1.274ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.2.3.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.2.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BM.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.5.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BN.1.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used